Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey A Toretsky

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Nature Medicine|July 9, 2009
A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcomaHayriye V Erkizan, Yali Kong, Melinda Merchant, et al.
The Journal of Biological Chemistry|June 18, 2011
Dipeptidyl peptidases as survival factors in Ewing sarcoma family of tumors: implications for tumor biology and therapyCongyi Lu, Jason U Tilan, Lindsay Everhart, et al.
Molecular and Cellular Biology|July 8, 2015
Ezrin Binds to DEAD-Box RNA Helicase DDX3 and Regulates Its Function and Protein LevelHaydar Çelik, Kamal P Sajwan, Saravana P Selvanathan, et al.
Nucleic Acids Research|January 8, 2015
RNA helicase A activity is inhibited by oncogenic transcription factor EWS-FLI1Hayriye Verda Erkizan, Jeffrey A Schneider, Kamal Sajwan, et al.
Cancer|November 13, 2014
Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survivalJason U Tilan, Mark Krailo, Donald A Barkauskas, et al.
Molecular Cancer Therapeutics|January 8, 2017
Combinatorial Drug Screening Identifies Ewing Sarcoma-specific SensitivitiesBranka Radic-Sarikas, Kalliopi P Tsafou, Kristina B Emdal, et al.
Nucleic Acids Research|August 9, 2019
EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complexSaravana P Selvanathan, Garrett T Graham, Alexander R Grego, et al.
Plos One|July 22, 2017
Osteosarcoma enters a post genomic era with in silico opportunities: Generation of the High Dimensional Database for facilitating sarcoma biology research: A report from the Children's Oncology Group and the QuadW FoundationJason Glover, Tsz-Kwong Man, Donald A Barkauskas, et al.
Plos One|December 6, 2014
A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft modelSaid Rahim, Tsion Minas, Sung-Hyeok Hong, et al.
Cancer Biology & Therapy|September 3, 2011
VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cellsLymor Ringer, Paul Sirajuddin, Mary Heckler, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Nature Medicine|July 9, 2009
A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcomaHayriye V Erkizan, Yali Kong, Melinda Merchant, et al.
The Journal of Biological Chemistry|June 18, 2011
Dipeptidyl peptidases as survival factors in Ewing sarcoma family of tumors: implications for tumor biology and therapyCongyi Lu, Jason U Tilan, Lindsay Everhart, et al.
Molecular and Cellular Biology|July 8, 2015
Ezrin Binds to DEAD-Box RNA Helicase DDX3 and Regulates Its Function and Protein LevelHaydar Çelik, Kamal P Sajwan, Saravana P Selvanathan, et al.
Nucleic Acids Research|January 8, 2015
RNA helicase A activity is inhibited by oncogenic transcription factor EWS-FLI1Hayriye Verda Erkizan, Jeffrey A Schneider, Kamal Sajwan, et al.
Cancer|November 13, 2014
Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survivalJason U Tilan, Mark Krailo, Donald A Barkauskas, et al.
Molecular Cancer Therapeutics|January 8, 2017
Combinatorial Drug Screening Identifies Ewing Sarcoma-specific SensitivitiesBranka Radic-Sarikas, Kalliopi P Tsafou, Kristina B Emdal, et al.
Nucleic Acids Research|August 9, 2019
EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complexSaravana P Selvanathan, Garrett T Graham, Alexander R Grego, et al.
Plos One|July 22, 2017
Osteosarcoma enters a post genomic era with in silico opportunities: Generation of the High Dimensional Database for facilitating sarcoma biology research: A report from the Children's Oncology Group and the QuadW FoundationJason Glover, Tsz-Kwong Man, Donald A Barkauskas, et al.
Plos One|December 6, 2014
A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft modelSaid Rahim, Tsion Minas, Sung-Hyeok Hong, et al.
Cancer Biology & Therapy|September 3, 2011
VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cellsLymor Ringer, Paul Sirajuddin, Mary Heckler, et al.
Pageof 9